Sanofi is pursuing several opportunities in MS, a debilitating nerve disease, to offset revenue losses after the recent end ...

After missing primary endpoints in relapsing forms of MS, tolebrutinib has proved its efficacy in secondary progressive MS ...

After missing primary endpoints in relapsing forms of MS, tolebrutinib has proved its efficacy in secondary progressive MS ...

Sanofi said on Friday that its multiple sclerosis drug candidate was shown to delay worsening of a progressive form of the ...

The specter of elevated liver enzymes, a known problem with the drug class, became a topic of talk with regard to Sanofi SA’s ...

Sanofi said on Friday that its multiple sclerosis drug candidate was shown to delay worsening of a progressive form of the ...

Multiple sclerosis (MS) is a neurodegenerative disease ... No specific clinical features of the eye disease have been identified that are unique to MS-associated uveitis. MS-associated uveitis ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any breaking news developments ...

Visual disturbances which are associated with neurological disorders and strokes are numerous and may have severe and diverse ...

Abnormal eye movements, asymmetric pupillary responses, sudden reading problems or the appearance of diplopia are all yellow ...

ST. GEORGE — The sounds of pingpong balls being hit back and forth filled a room in the St. George Recreation Center as a ...

Christina Applegate's revealed her multiple sclerosis (MS) diagnosis publicly in 2021. Here's everything she's said about the ...